中文 | English
Return
Total: 67 , 1/7
Show Home Prev Next End page: GO
Author:(LI MINGCHUN)

1.Effect of Atorvastatin on Cardiac Function and Plasma C-reactiveprotein and Uric Acid Elevels in Patients Ischemic Cardiomyopathy

Mingchun LI ; Jilie LIU

Journal of Medical Research 2006;0(10):-

2.Progress in biomarkers of non-small cell lung cancer for individualized treatment

Changjiao LIU ; Mingchun LI

Chinese Journal of Pharmacology and Toxicology 2016;30(4):375-380

3.The inhibitory effect of 3', 5'-cCMP on the production of human interleukin-2 and the expression of interleukin-2 receptors in vitro

Mingchun WANG ; Yangqiu LI

Chinese Journal of Pathophysiology 1989;0(05):-

4.Chronopharmacokinetics of gefitinib and its mechanisms in tumor-bearing nude mice

Le WANG ; Changjiao LIU ; Mingchun LI

Chinese Journal of Pharmacology and Toxicology 2016;(2):144-150

5.Roles of miR-494 in tumors

Mingchun LI ; Aibing WU ; Zhixiong YANG

Journal of International Oncology 2013;40(10):726-729

6.Study on the transfection of dextran derivative nanoparticles to the mda-mb-435 human breast cancer cells

Mingchun LI ; Dongsheng LIANG ; Youwei LI ; Li LIU

Chinese Pharmacological Bulletin 2003;0(08):-

7.Study of Effective Substances Screening for Panax Notoginseng Based on Spectrum-effect Relationship

Xu LIU ; Xiao LI ; Xiaobo CUI ; Mingchun LI

China Pharmacist 2016;19(2):205-209

8.Chronopharmacokinetics of erlotinib in tumor-bearing mice

Jiao LIU ; Mingchun LI ; Peipei WANG ; Bin ZHANG

Chinese Journal of Pharmacology and Toxicology 2014;(3):403-407

9.Effect of chitosan on PKC activity and DAG concentration in murine peritoneal macrophages

Dongsheng LIANG ; Mingchun LI ; Fengmei AN ; Yuejun WANG ; Jinhua YUAN

Chinese Pharmacological Bulletin 1986;0(06):-

10.Improvement of Quality Standard for Weiling Granules

Yanqin CHENG ; Songgang JI ; Liyan ZHAO ; Mingchun LI

China Pharmacist 2015;18(10):1720-1723

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 67 , 1/7 Show Home Prev Next End page: GO